Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Hepatosplenic gamma-delta T-cell lymphoma.

Ferreri AJ, Govi S, Pileri SA.

Crit Rev Oncol Hematol. 2012 Aug;83(2):283-92. doi: 10.1016/j.critrevonc.2011.10.001. Review.

PMID:
22047938
2.

Hepatosplenic gamma delta T-cell lymphoma. A distinctive aggressive lymphoma type.

Wong KF, Chan JK, Matutes E, McCarthy K, Ng CS, Chan CH, Ma SK.

Am J Surg Pathol. 1995 Jun;19(6):718-26. Review.

PMID:
7755158
4.

Challenges and new prospects in hepatosplenic γδ T-cell lymphoma.

Calvaruso M, Gulino A, Buffa S, Guarnotta C, Franco G, Cacciatore M, Bonura MG, Franco V, Florena AM.

Leuk Lymphoma. 2014 Nov;55(11):2457-65. doi: 10.3109/10428194.2014.889821. Review.

PMID:
24506469
5.

Hepatosplenic γδ T-cell lymphoma: an overview.

Visnyei K, Grossbard ML, Shapira I.

Clin Lymphoma Myeloma Leuk. 2013 Aug;13(4):360-9. doi: 10.1016/j.clml.2013.03.011. Review.

PMID:
23876844
6.

Hepatosplenic gammadelta T-cell lymphoma following seven malaria infections.

Hassan R, Franco SA, Stefanoff CG, Romano SO, Diamond HR, Franco LG, Seuánez HN, Zalcberg IR.

Pathol Int. 2006 Nov;56(11):668-73.

PMID:
17040289
7.

Hepatosplenic gammadelta T-cell lymphoma in a 10-year-old boy successfully treated with hematopoietic stem cell transplantation.

Gassas A, Kirby M, Weitzman S, Ngan B, Abla O, Doyle JJ.

Am J Hematol. 2004 Feb;75(2):113-4.

8.

Hepatosplenic T-cell lymphoma: clinicopathologic, immunophenotypic, and molecular characterization of 17 Chinese cases.

Lu CL, Tang Y, Yang QP, Wang M, Zhao S, Bi CF, Jiang NG, Zhang WY, Liu JP, Xu X, Liu WP.

Hum Pathol. 2011 Dec;42(12):1965-78. doi: 10.1016/j.humpath.2011.01.034.

PMID:
21683978
9.

Hepatosplenic gamma-delta T-cell lymphoma as a late-onset posttransplant lymphoproliferative disorder in renal transplant recipients.

Wu H, Wasik MA, Przybylski G, Finan J, Haynes B, Moore H, Leonard DG, Montone KT, Naji A, Nowell PC, Kamoun M, Tomaszewski JE, Salhany KE.

Am J Clin Pathol. 2000 Apr;113(4):487-96.

10.
11.

Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen.

Tey SK, Marlton PV, Hawley CM, Norris D, Gill DS.

Am J Hematol. 2008 Apr;83(4):330-3. Review.

12.

Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas.

Macon WR, Levy NB, Kurtin PJ, Salhany KE, Elkhalifa MY, Casey TT, Craig FE, Vnencak-Jones CL, Gulley ML, Park JP, Cousar JB.

Am J Surg Pathol. 2001 Mar;25(3):285-96.

PMID:
11224598
13.

Hepatosplenic alphabeta T cell lymphoma.

Nagai Y, Ikegame K, Mori M, Inoue D, Kimura T, Shimoji S, Togami K, Tabata S, Kurata M, Imai Y, Matsushita A, Nagai K, Ogawa H, Takahashi T.

Int J Clin Oncol. 2010 Apr;15(2):215-9. doi: 10.1007/s10147-010-0028-y.

PMID:
20217452
14.

Pentostatin (2'-deoxycoformycin) for the treatment of hepatosplenic gammadelta T-cell lymphomas.

Corazzelli G, Capobianco G, Russo F, Frigeri F, Aldinucci D, Pinto A.

Haematologica. 2005 Mar;90(3):ECR14.

15.

Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin.

Cooke CB, Krenacs L, Stetler-Stevenson M, Greiner TC, Raffeld M, Kingma DW, Abruzzo L, Frantz C, Kaviani M, Jaffe ES.

Blood. 1996 Dec 1;88(11):4265-74.

16.

Hepatosplenic gamma/delta T-cell lymphoma in immunocompromised patients. Report of two cases and review of literature.

Khan WA, Yu L, Eisenbrey AB, Crisan D, al Saadi A, Davis BH, Hankin RC, Mattson JC.

Am J Clin Pathol. 2001 Jul;116(1):41-50. Review.

17.

Allogeneic bone marrow transplantation for chemotherapy-refractory hepatosplenic gammadelta T-cell lymphoma: case report and review of the literature.

Domm JA, Thompson M, Kuttesch JF, Acra S, Frangoul H.

J Pediatr Hematol Oncol. 2005 Nov;27(11):607-10.

PMID:
16282893
18.

Hepatosplenic T cell lymphoma responsive to 2'-deoxycoformycin therapy.

Bennett M, Matutes E, Gaulard P.

Am J Hematol. 2010 Sep;85(9):727-9. doi: 10.1002/ajh.21774.

19.

2'-Deoxycoformycin for hepatosplenic gammadelta T-cell lymphoma.

Grigg AP.

Leuk Lymphoma. 2001 Aug;42(4):797-9.

PMID:
11697510
20.

Hepatosplenic gammadelta T-cell lymphoma: ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation.

Salhany KE, Feldman M, Kahn MJ, Peritt D, Schretzenmair RD, Wilson DM, DiPaola RS, Glick AD, Kant JA, Nowell PC, Kamoun M.

Hum Pathol. 1997 Jun;28(6):674-85.

PMID:
9191001
Items per page

Supplemental Content

Support Center